Abstract:
Un procédé pour le recyclage d'un matériau d'électrode comprenant du graphène et un matériau électrochimiquement actif est décrit. Le procédé comprend une étape d'addition, dans un ordre quelconque, d'eau et d'un solvent non miscible au matériau d'électrode, formant ainsi un système biphasique comprenant une phase organique et une phase aqueuse; et une étape de séparation et de filtration de la phase organique pour récupérer le graphène. Le procédé comprend éventuellement des étapes additionnelles de lavage, séchage et/ou de traitement thermique. Les électrodes comprenant le graphène recyclé, de même que les cellules électrochimiques et leurs utilisations sont aussi décrites.
Abstract:
The present invention relates to a seating device (11) comprising a connecting element (12) having an end portion (22) dimensioned to be releasably and rotatably inserted into an aperture defined in a ground or floor. The aperture is dimensioned to receive the connecting element (12) so as to support the seating device (11). The seating device (11) also comprises a supporting element (14) connected to a seat (16). The supporting element (14) is pivotably connected to the connecting element (12). Moreover, at least one of the connecting element (12) and supporting element (14) comprises at least one stop (24) so as to permit the supporting element (14) to pivot between a first position whereat the supporting element (14) is in a substantially vertical position, and a second position whereat the supporting element (14) is forwardly inclined of 30 degrees or less with respect to the first position. Such a device is particularly useful for persons who need to stabilize their posture while performing a task.
Abstract:
An electrode includes a plurality of nanomaterial members that define a plurality of pores. The electrode allows passage of at least 60% of light in the about 390 nm to about 1200 nm wavelength range. The electrode can be used for measuring capacitance, resistance, inductance, electrochemical properties and/or photoelectric properties of an element to be analyzed. A process for fabricating the electrode includes forming on a substrate a conductive pattern comprising a plurality of conductive nanomaterial members and optionally functionalizing a first sub-region of the conductive pattern with a material sensitive to at least a first type of analyte. The conductive pattern can comprise a plurality of pores, and the formed electrode allows passage of at least 60% of light in the about 390 nm to about 1200 nm wavelength range. A detector includes a working electrode, a counter electrode and a reference electrode, each electrode having a plurality of nanomaterials defining a plurality of pores.
Abstract:
The present invention relates to the field of rotavirus and more particularly to VP5/VP8 Rotavirus polypeptides, polynucleotides encoding same, and their use for eliciting an immune response against rotavirus infections.
Abstract:
There are provided processes for preparing compounds of formula (I) AMPO4. The processes comprise reacting a compound or formula (II) AH 2 PO 4 and a compound of formula (III) MX n , in the presence of an acid scavenger adapted to at least substantially solubilize the compound of formula (II) and the compound of formula (III), at a predetermined temperature, and adapted to be converted into a protic ionic liquid upon protonation. A, M, and X can be various chemical entities and n can be 1 or 2. A process for preparing electrodes is also provided.
Abstract:
The present invention relates to an electrode comprising a non-conductive substrate, a first layer and a second layer. The first layer is disposed on the substrate and comprises indium tin oxide or fluorine-doped Sn0 2 . The second layer is disposed on the first layer and comprises CoS. A process for preparing this electrode is also disclosed. Such an electrode is particularly useful in a photovoltaic cell.
Abstract:
The present disclosure relates to peptide compounds and conjugate compounds, processes, methods and uses thereof for treating cancer. For example, the compounds can comprise compounds of formula (SEQ ID NO: 1) X1X2X3X4X5GVX6AKAGVX7NX8FKSESY (I) (SEQ ID NO: 2) (X9)nGVX10AKAGVX11NX12FKSESY (II) (SEQ ID NO: 3) YKX13LRRX14APRWDX15PLRDPALRX16X17L (III) (SEQ ID NO: 4) YKX18LRR(X19)nPLRDPALRX20X21L (IV) (SEQ ID NO: 5) IKLSGGVQAKAGVINMDKSESM (V) (SEQ ID NO: 6) IKLSGGVQAKAGVINMFKSESY (VI) (SEQ ID NO: 7) IKLSGGVQAKAGVINMFKSESYK (VII) (SEQ ID NO: 8) GVQAKAGVINMFKSESY (VIII) (SEQ ID NO: 9) GVRAKAGVRNMFKSESY (IX) (SEQ ID NO: 10) GVRAKAGVRN(Nle)FKSESY (X) (SEQ ID NO: 11) YKSLRRKAPRWDAPLRDPALRQLL (XI) (SEQ ID NO: 12) YKSLRRKAPRWDAYLRDPALRQLL (XII) (SEQ ID NO: 13) YKSLRRKAPRWDAYLRDPALRPLL (XIII) wherein X1 to X21 and n can have various different values and wherein at least one protecting group and/or at least one labelling agent is optionally connected to said peptide compound at an N- and/or C-terminal end.
Abstract:
This application describes a process for the preparation of flexible electrode-separator elements or assemblies, which includes the application of an electrode material on the separator. The electrode material comprises graphene, for instance produced by graphite exfoliation. The electrode-separator elements obtained by the process as well as their use in electrochemical cells are also described.
Abstract:
Immunogenic compositions comprising a p97 adhesin adjuvant polypeptide, or a nucleic acid encoding said p97 adhesin adjuvant polypeptide, and a heterologous antigen are disclosed. Uses of the p97 adhesin adjuvant polypeptide or nucleic acid, or immunogenic compositions comprising same, for inducing an immune response against a heterologous antigen in a subject are also disclosed.
Abstract:
The present disclosure relates to peptide compounds and conjugate compounds, processes, methods and uses thereof for treating cancer. For example, the compounds can comprise compounds of formula
(SEQ ID NO: 1)
X1X2X3X4X5GVX6AKAGVX7NX8FKSESY
(I)
(SEQ ID NO: 2)
(X9)nGVX10AKAGVX11NX12FKSESY
(II)
(SEQ ID NO: 3)
YKX13LRRX14APRWDX15PLRDPALRX16X17L
(III)
(SEQ ID NO: 4)
YKX18LRR(X19)nPLRDPALRX20X21L
(IV)
(SEQ ID NO: 5)
IKLSGGVQAKAGVINMDKSESM
(V)
(SEQ ID NO: 6)
IKLSGGVQAKAGVINMFKSESY
(VI)
(SEQ ID NO: 7)
IKLSGGVQAKAGVINMFKSESYK
(VII)
(SEQ ID NO: 8)
GVQAKAGVINMFKSESY
(VIII)
(SEQ ID NO: 9)
GVRAKAGVRNMFKSESY
(IX)
(SEQ ID NO: 10)
GVRAKAGVRN(Nle)FKSESY
(X)
(SEQ ID NO: 11)
YKSLRRKAPRWDAPLRDPALRQLL
(XI)
(SEQ ID NO: 12)
YKSLRRKAPRWDAYLRDPALRQLL
(XII)
(SEQ ID NO: 13)
YKSLRRKAPRWDAYLRDPALRPLL
(XIII)
wherein X1 to X21 and n can have various different values and wherein at least one protecting group and/or at least one labelling agent is optionally connected to said peptide compound at an N- and/or C-terminal end.